[Click the thumbnails below to view the videos.]
Video #1: In atopic dermatitis, nonlesional skin is not normal skin
Video #2: Genetic signature of nonlesional skin is similar to lesional skin in atopic dermatitis
Video #3: IL-4 and IL-13, key Th2 cytokines, drive immune dysregulation in atopic dermatitis
Video #4: Atopic dermatitis is driven by persistent immune dysregulation
Video #5: What is driving atopic dermatitis: the “inside-out” or “outside-in” model?
Video #6: Similarities and differences between atopic dermatitis and psoriasis
Learn more at www.atopicdermatitisexposed.com
Sponsored Content: This educational program has been developed by Regeneron Pharmaceuticals and Sanofi Genzyme.
1. De Benedetto A, Rafaels NM, McGirt LY, et al. Tight junction defects in patients with atopic dermatitis. J Allergy Clin Immunol. 2011;127(3):773-786. 2. Gittler JK, Shemer A, Suárez-Fariñas M, et al. Progressive activation of TH2/TH22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis. J Allergy Clin Immunol. 2012;130(6):1344-1354. 3. Leung DYM, Boguniewicz M, Howell MD, Nomura I, Hamid QA. New insights into atopic dermatitis. J Clin Invest. 2004;113(5):651-657. 4. Suárez-Fariñas M, Tintle SJ, Shemer A, et al. Nonlesional atopic dermatitis skin is characterized by broad terminal differentiation defects and variable immune abnormalities. J Allergy Clin Immunol. 2011;127(4):954-964.